coadministered cagrilintide and semaglutide in adults with overweight or obesity together drive record weight loss global trial In the REDEFINE 2 phase
In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Cagrilintide Peptide Dosing Guide: Titration, Schedule & Safety (2026) Order Cagrilintide 5mg+Semaglutide 5mg Buy Research Peptides Medica Depot CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes New England Journal of Medicine
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



